The Safety and Efficacy of Fluoxetine for the Treatment of Refractory Primary Monosymptomatic Nocturnal Enuresis in Children: A Randomized Placebo-Controlled Trial.

Mohamed HussinyAbdelwahab HashemMohamed A SoltanTamer E HelmyMahmoud R El-KenawyAhmed Abdelhalim

Published in: The Journal of urology (2022)

Fluoxetine is safe treatment for refractory primary monosymptomatic nocturnal enuresis in children with good initial response that declines at 12 weeks.

Keyphrases

young adults
blood pressure
randomized controlled trial
physical activity
replacement therapy